Elmahallawy Ehab Kotb, Mohamed Yasser, Abdo Walied, El-Gohary Fatma A, Ahmed Awad Ali Shaimaa, Yanai Tokuma
Department of Zoonoses, Faculty of Veterinary Medicine, Sohag University, Sohag, Egypt.
Laboratory of Kafr El Sheikh Fever Hospital, Kafr El Sheikh Fever Hospital, Kafr El-Sheikh, Egypt.
Front Mol Biosci. 2021 Feb 8;7:618318. doi: 10.3389/fmolb.2020.618318. eCollection 2020.
The recent emergence of COVID-19 represents one of the biggest challenges facing the world today. Despite the recent attempts to understand the epidemiological pattern and pathogenesis of the disease, detailed data about the physiology and pathology of the disease is still out of reach. Moreover, the lack of a widespread vaccine prompts an urgent call for developing a proper intervention strategy against the virus. Importantly, identification of novel molecules that target replication of the virus represents one of the promising strategies for the control this pandemic crisis. Among others, honey bee products contain numerous bioactive compounds such as propolis and several phenolic compounds that possess a wide range of therapeutic properties for combating various pathological disorders and infectious agents. The intention of the present review is to highlight the stages of SARS-CoV-2 lifecycle, the molecular mechanisms explaining the health benefits of honey bee products on COVID-19 physiology and pathology and the possible limitations. Further future research is suggested to explore more about bee natural bioactive compounds as potential candidates against SARS-CoV-2.
新型冠状病毒肺炎(COVID-19)的近期出现是当今世界面临的最大挑战之一。尽管最近人们试图了解该疾病的流行病学模式和发病机制,但有关该疾病生理和病理的详细数据仍然难以获得。此外,缺乏广泛使用的疫苗促使人们迫切呼吁制定针对该病毒的适当干预策略。重要的是,鉴定靶向病毒复制的新型分子是控制这一全球大流行危机的有前景的策略之一。其中,蜜蜂产品含有多种生物活性化合物,如蜂胶和几种酚类化合物,它们具有广泛的治疗特性,可对抗各种病理疾病和感染因子。本综述的目的是强调严重急性呼吸综合征冠状病毒2(SARS-CoV-2)生命周期的各个阶段、解释蜜蜂产品对COVID-19生理和病理有益健康作用的分子机制以及可能存在的局限性。建议未来进一步开展研究,以更深入地探索蜜蜂天然生物活性化合物作为抗SARS-CoV-2潜在候选物的可能性。